Quimby Investments
Quimby Investments is a venture capital firm established in 2002 and located in British Columbia, Canada. The firm focuses on identifying and investing in early-stage companies across various sectors, aiming to support innovative entrepreneurs and foster growth within the Canadian market. Quimby Investments is committed to providing strategic guidance and resources to its portfolio companies, helping them navigate the challenges of scaling and achieving long-term success. Through its investment activities, the firm seeks to contribute to the development of the regional economy while delivering returns to its investors.
Top Regions
Top Stages
https://crunchbase.com/organization/***
3 past transactions
Variational AI
Seed Round in 2025
Variational AI employs cutting-edge machine learning techniques to swiftly generate novel compounds optimized for multiple properties. This approach aims to mitigate common causes of drug failure and enhance clinical success. The company collaborates with leading biopharmaceutical partners and maintains its own pipeline.
Arbutus Medical
Seed Round in 2020
Founded in 2014, Arbutus Medical develops and manufactures surgical power tools aimed at reducing healthcare costs. Its flagship product is a radically affordable orthopedic power tool system used in trauma centers, veterinary hospitals, military deployments, and hospitals worldwide.
LightIntegra Technology
Series A in 2019
LightIntegra Technology Inc., established in 2009 and headquartered in Vancouver, Canada, is a privately-funded medical diagnostics company specializing in innovative in-vitro diagnostic tests. The company's flagship product, ThromboLUX, is designed to provide healthcare professionals with qualitative and quantitative information about microparticle content in platelet samples. LightIntegra offers the ThromboLUX test kit, control kit, and ThromboSight, a software tool for analyzing test results. Founded by Dr. Elisabeth Maurer, a research scientist from Canadian Blood Services R&D labs, the company aims to minimize platelet refractoriness through its products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.